作者: Calvin L. Weisberger , Nicholas Ruggiero , Eward K. Chung
DOI: 10.1007/978-3-642-86000-3_5
关键词:
摘要: In this era of the coronary care unit and electrocardiographc monitoring patients with acute myocardial infarction, a major problem is that cardiogenic shock. Some 10 to 20 percent hospitalized infarction experience „pump failure“ or shock (2). Of these patients, 80 100 die as direct result state (27). Various approaches management entity have been used by different investigators (11, 21, 29), yet, significant controversy exists ideal therapeutic approach proper selection various pharmacologic agents in